Perrigo's generic dermatitis drug gains FDA nod

08/1/2013 | Drug Store News

Perrigo obtained federal approval for its fluticasone propionate lotion in the 0.05% strength to address inflammatory and pruritic manifestations of atopic dermatitis in pediatric patients ages 1 and older. The drug is a generic copy of PharmaDerm's Cutivate.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ